Organ-specific immune responses associated with infectious disease

Immunology Today

Volumn 21, Issue 2, 2000, Pages 73-78

  Engwerda, Christian R ^a   Kaye, Paul M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; HUMAN; IMMUNOPATHOGENESIS; INFECTION RESISTANCE; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; NATURAL KILLER CELL; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TISSUE SPECIFICITY; VISCERAL LEISHMANIASIS;

EID: 0034141801     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(99)01549-2     Document Type: Note

References (47)

1. Adorini L.et al. Manipulation of the Th1/Th2 cell balance: an approach to treat human autoimmune diseases? Autoimmunity. 23:1996;53-68.
2. De Maria R., Testi R. Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. Immunol. Today. 19:1998;121-125.
3. Zinkernagel R.M.et al. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev. 156:1997;199-209.
4. Von-Herrath M.G.et al. Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system. Immunol. Rev. 152:1996;111-143.
5. Barry M., McFadden G. Apoptosis regulators from DNA viruses. Curr. Opin. Immunol. 10:1998;422-430.
6. Gardner P.J. Taxonomy of the Genus Leishmania: a review of nomenclature and classification. Trop. Dis. Bull. 74:1977;1069-1088.
7. Bryceson A.D.M. Cook G.C. Manson's Tropical Diseases. 1996;1213-1245 Saunders.
8. Wilson M.E.et al. Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J. Immunol. 156:1996;2231-2239.
9. Smelt S.C.et al. Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J. Immunol. 158:1997;3813-3821.
10. Bradley D.J., Kirkley J. Regulation of Leishmania populations within the host. I. The variable course of Leishmania donovani infections in mice. Clin. Exp. Immunol. 30:1977;119-129.
11. Rees P.H.et al. Splenectomy in kala azar. Trop. Geogr. Med. 36:1984;285-292.
12. Conlan J.W. Early pathogenesis of Listeria monocytogenes infection in the mouse spleen. J. Med. Microbiol. 44:1996;295-302.
13. Blackwell J.M. Leishmania donovani infection in heterozygous and recombinant H-2 haplotype mice. Immunogenetics. 18:1983;101-109.
14. Kaye P.M. Acquisition of cell-mediated immunity to Leishmania. I. Primary T-cell activation detected by IL-2 receptor expression. Immunology. 61:1987;345-349.
15. Gorak P.M.A.et al. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur. J. Immunol. 28:1998;687-695.
16. Reis e Sousa C.et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186:1997;1819-1829.
17. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:1993;567-577.
18. Suss G., Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183:1996;1789-1796.
19. + dendritic cells (DC) veto cells? The role of CD8 on DC in DC development and in the regulation of CD4 and CD8 T cell responses. Int. Immunol. 9:1997;1061-1064.
20. Reis e Sousa C.et al. The role of dendritic cells in the induction and regulation of immunity to microbial infection. Curr. Opin. Immunol. 11:1999;392-399.
21. Engwerda C.R.et al. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Eur. J. Immunol. 28:1998;669-680.
22. Murray H.W. Blood monocytes: differing effector role in experimental visceral versus cutaneous leishmaniasis. Parasitol. Today. 10:1994;220-223.
23. Steptoe R.J.et al. Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J. Immunol. 159:1997;5483-5491.
24. Cotterell S.E.J.et al. Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent manner. Eur. J. Immunol. 29:1999;203-214.
25. Crispe I.N., Mehal W.Z. Strange brew: T cells in the liver. Immunol. Today. 17:1996;522-525.
26. Bendelac A.et al. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:1997;535-562.
27. Engwerda C.R.et al. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice. Exp. Parasitol. 84:1996;195-202.
28. Murray H.W.et al. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. J. Immunol. 148:1992;1858-1863.
29. Murray H.W. Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. J. Infect. Dis. 175:1997;1477-1479.
30. Carrera L.et al. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183:1996;515-526.
31. Belkaid Y.et al. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. Eur. J. Immunol. 28:1998;1389-1400.
32. Descoteaux A., Turko S.J. The lipophosphoglycan of leishmania and macrophage protein kinase C. Parasitol. Today. 9:1993;468-471.
33. Stenger S.et al. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:1994;783-793.
34. Rodrigues V.et al. Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis. Infect. Immun. 66:1998;1233-1236.
35. Wilson M.E.et al. The importance of TGF-β in murine visceral leishmaniasis. J. Immunol. 161:1998;6148-6155.
36. Humphrey J.H., Grennan D. Different macrophage populations distinguished by means of fluorescent polysaccharides. Recognition and properties of marginal-zone macrophages. Eur. J. Immunol. 11:1981;221-228.
37. Kaye P.M. Costimulation and the regulation of antimicrobial immunity. Immunol. Today. 16:1995;423-427.
38. Dutton R.W.et al. T cell memory. Annu. Rev. Immunol. 16:1998;201-224.
39. Saito T. Negative regulation of T cell activation. Curr. Opin. Immunol. 10:1998;313-321.
40. Murphy M.L.et al. Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani. J. Immunol. 161:1988;4153-4160.
41. North R.J., Izzo A.A. Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity. J. Exp. Med. 177:1993;1723-1733.
42. Chensue S.W.et al. Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks. J. Immunol. 159:1997;3565-3573.
43. Fox C.H., Cottler-Fox M. The pathobiology of HIV infection. Immunol. Today. 13:1992;353-356.
44. Lyons A.B., Parish C.R. Are murine marginal-zone macrophages the splenic white pulp analog of high endothelial venules? Eur. J. Immunol. 25:1995;3165-3172.
45. Barnes P.F.et al. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:1993;3482-3489.
46. Tapia F.J.et al. Tapia F.J.et al. Molecular Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis. 1996;139-152 Springer.
47. Castes M. Tapia F.J.et al. Molecular Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis. 1996;203-221 Springer.